Wheeler Bio, Inc., a U.S.-based contract development and biomanufacturing organization (CDMO), has established a strategic partnership with Pharmefex Consulting, a CMC consultancy, focused on accelerating client success in Investigational New Drug (IND) filings and regulatory submissions. This collaboration enhances Wheeler’s ModularCMC platform by integrating the preparation of high-quality Common Technical Document (CTD) Module 3 documentation, supporting IND submissions for programs ...